Zealand Pharma wants to be world-leading within five years
BY MARTIN HAVTORN PETERSEN
Within the next half decade, Zealand Pharma aims to be one of the world leaders in treatment of rare metabolic disorders and gastrointestinal diseases. The foundation for success will be laid this year with four late-phase programs and an upcoming launch of two self-owned drugs.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.